GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SPA (NYSE:STVN) » Definitions » Book Value per Share

Stevanato Group SPA (Stevanato Group SPA) Book Value per Share : $5.30 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stevanato Group SPA Book Value per Share?

Stevanato Group SPA's book value per share for the quarter that ended in Mar. 2024 was $5.30.

During the past 12 months, Stevanato Group SPA's average Book Value Per Share Growth Rate was 27.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 53.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Stevanato Group SPA was 58.50% per year. The lowest was 53.70% per year. And the median was 56.10% per year.

Stevanato Group SPA's current price is $19.97. Its book value per share for the quarter that ended in Mar. 2024 was $5.30. Hence, today's PB Ratio of Stevanato Group SPA is 3.77.

During the past 6 years, the highest P/B Ratio of Stevanato Group SPA was 18.75. The lowest was 3.77. And the median was 6.11.

Good Sign:

Stevanato Group SPA stock PB Ratio (=3.77) is close to 3-year low of 3.77


Stevanato Group SPA Book Value per Share Historical Data

The historical data trend for Stevanato Group SPA's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stevanato Group SPA Book Value per Share Chart

Stevanato Group SPA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial 1.00 1.28 3.60 3.99 4.65

Stevanato Group SPA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.17 4.31 4.41 4.65 5.30

Competitive Comparison of Stevanato Group SPA's Book Value per Share

For the Medical Instruments & Supplies subindustry, Stevanato Group SPA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stevanato Group SPA's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SPA's PB Ratio distribution charts can be found below:

* The bar in red indicates where Stevanato Group SPA's PB Ratio falls into.



Stevanato Group SPA Book Value per Share Calculation

Stevanato Group SPA's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1,235-0)/265
=4.65

Stevanato Group SPA's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1,446-0)/273
=5.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Stevanato Group SPA  (NYSE:STVN) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Stevanato Group SPA Book Value per Share Related Terms

Thank you for viewing the detailed overview of Stevanato Group SPA's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Stevanato Group SPA (Stevanato Group SPA) Business Description

Traded in Other Exchanges
Address
Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% from South America. It has two segments Biopharmaceutical and Diagnostic Solutions and Engineering.